Figure 5From: Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic Box plots (median, lower and upper quartiles and range) of rate of change in eGFR during follow-up: (A) according to genotype and (B) after onset of CKD3. Back to article page